Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)

Market Cap	21.84B +4.2%
Revenue (ttm)	613.24M +114.2%
Net Income	-277.82M
EPS	-0.27
Shares Out	1.03B
PE Ratio	n/a
Forward PE	207.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,624,308
Open	22.00
Previous Close	21.18
Day's Range	20.52 - 22.00
52-Week Range	19.64 - 35.34
Beta	1.46
Analysts	Strong Buy
Price Target	36.31 (+71.44%)
Earnings Date	Aug 27, 2026

About HKG:2252

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People’s Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR’obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 464
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2252

Financial Performance

In 2025, HKG:2252's revenue was 551.07 million, an increase of 114.22% compared to the previous year's 257.25 million. Losses were -249.66 million, -61.14% less than in 2024.

Financial numbers in CNY

Analyst Summary

According to 10 analysts, the average rating for 2252 stock is "Strong Buy." The 12-month stock price target is $36.31, which is an increase of 71.44% from the latest price.

Price Target

$36.31

(71.44% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 10, 2026

Data Sources Report a data error